Long-Term Outcomes Following Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy in High-Risk Prostate Cancer: Update from the FASTR/FASTR-2 Trials – Beyond the Abstract
prostate cancer, Brief Androgen Suppression and Stereotactic Radiation Therapy, High-Risk Prostate Cancer, FASTR trial, FASTR-2 Trials, stereotactic ablative radiotherapy (SABR), SABR in high-risk prostate cancer.